@genxshopfinds76's testosterone claims for women, reviewed

What did @genxshopfinds76 actually say?

A nurse practitioner named Jen made the case that low testosterone in women produces symptoms including fatigue, low libido, brain fog, mood swings, anxiety, and muscle loss despite exercise. She framed testosterone as "your strength, your spark, and your confidence" and pushed back on the idea that these symptoms are just aging. Her clinical approach: optimize estrogen and progesterone first, then add testosterone as a "cherry on top." That sequencing detail is actually more clinically thoughtful than most TikTok hormone content, and it matters.

She did not cite lab values, dosing, or specific diagnoses. She kept things general, which is a reasonable lane for a short-form video. But general can also mean oversimplified, so let's look at what the evidence actually says.

Does the science back this up?

Mostly, yes, but with important caveats the video does not mention. Testosterone does decline in women with age, and research does connect low levels to some of the symptoms she listed. The Global Consensus Position Statement on testosterone use in women, published in 2019 in the Journal of Clinical Endocrinology and Metabolism by Baber et al., concluded that testosterone therapy in postmenopausal women has evidence specifically for treating hypoactive sexual desire disorder. That is the most evidence-supported use case.

The other symptoms she listed, such as fatigue, brain fog, anxiety, and muscle loss, are real complaints in perimenopause and menopause, but the evidence linking them specifically to testosterone deficiency rather than estrogen deficiency or general aging is weaker. Davis et al. (2019, Climacteric) noted that many of these overlapping symptoms are driven primarily by estrogen decline, not testosterone. Attributing them primarily to low testosterone without that nuance is an overreach.

What did they get wrong (or right)?

She got the sequencing right. Prioritizing estrogen and progesterone before adding testosterone is consistent with clinical guidance. The 2019 Global Consensus Statement explicitly does not recommend testosterone as a first-line hormone therapy for menopause symptoms, which aligns with her "cherry on top" framing.

What she got wrong, or at least incomplete: the symptom list she presented is broad enough to describe dozens of conditions, including thyroid dysfunction, depression, iron deficiency anemia, and sleep apnea. Presenting these symptoms as a testosterone-specific cluster without mentioning differential diagnosis is misleading in a subtle way. A viewer watching this may self-identify as having "low T" when they actually need a thyroid panel or a sleep study.

She also never mentioned that testosterone therapy for women is largely off-label in the United States. No FDA-approved testosterone product exists specifically for women. That is not disqualifying, but it is something a patient deserves to know before seeking treatment.

What should you actually know?

If you relate to this symptom list, start with bloodwork, not assumptions. Testosterone levels in women are notoriously difficult to interpret because standard assays are calibrated for male ranges. Davis et al. (2018, Lancet Diabetes and Endocrinology) specifically flagged the unreliability of commonly used immunoassays for measuring testosterone in women. You need a provider who orders the right test, a high-sensitivity liquid chromatography-mass spectrometry assay, and knows how to interpret results in the context of your full hormone panel.

Also worth knowing: the symptoms Jen described overlap substantially with perimenopause driven by estrogen loss, not testosterone loss. If you are in your 40s and experiencing brain fog, mood swings, and fatigue, estrogen therapy may do more for those complaints than testosterone will. That is not a reason to avoid testosterone, it is a reason to not skip the diagnostic step.

• Testosterone therapy for women is off-label in the U.S. No FDA-approved formulation exists for women.
• The strongest clinical evidence for testosterone in women is for low libido, specifically hypoactive sexual desire disorder.
• Many symptoms attributed to low testosterone in perimenopause overlap with low estrogen and should be evaluated together.
• Lab testing for testosterone in women requires high-sensitivity assays. Standard panels may not be accurate enough.